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The aim of the study was to determine the eﬀect of ginseng and echinacea on the mRNA expression of IL-10, TNF-α,a n dT G F - β1
in healthy rats. Six-week-old male Fischer 344 rats (n = 48) were used. The animals were divided into three equal groups, as
follows: control (C); ginseng (G); echinacea (E). While the C group was fed a standard rat diet (Purina) ad libitum for a period
of 40 days, the G and E groups animals received the same diet containing 0.5g/kg of Panax ginseng root powder and 0.75g/kg
of Echinacea purpurea root powder, respectively. Blood samples were obtained from 8 rats in each group after 20 and 40 days of
treatment, and the mRNA expression of IL-10, TNF-α,a n dT G F - β1 was determined. After 20 days of treatment, the expression of
IL-10mRNAintheGgroupwasdiﬀerentfromtheCgroup(P<0.05);however,after40daysoftreatment,therewas nodiﬀerence
between the groups. There was no diﬀerence after 20 and 40 days of treatment between the groups with respect to the expression
of TGF-β1 mRNA. After 20 days of treatment, the expression of TNF-α mRNA in the E group was higher (P<0.05) than the C
group. After 40 days of treatment, the expression of TNF-α mRNA was similar in all of the groups. Based on the current study,
the increase in expression of IL-10 mRNA in the G group and the increase in expression of TNF-α mRNA in the E group support
the use of these plants for purposes of modulating the immune system. However, a more detailed study regarding the eﬀects of
ginseng and echinacea on these cytokines and other cytokines is needed.
1.Introduction
Ginseng refers to the root of several species in the plant
genus Panax (C. A. Meyer Araliaceae), including P. ginseng,
P. japonicas, P. quinquefolium,a n dP. notoginseng [1].
Recently, P. ginseng has been widely used worldwide as an
ingredient in dietary health supplements and an additive
in foods [2]. The glycosidal saponins (glycosylated steroids)
known as ginsenosides are the main active components
of ginseng [3]. Based on several studies, tonic, immuno-
modulatory, antimutagenic, and antiageing activities have
been reported among the pharmacologic properties of
ginseng [4, 5]. Clinical studies have also demonstrated
that ginseng may improve immunostimulation, antitumor
activity, cardiovascular function, antioxidant activity, hypo-
glycemic activity, and the pituitary-adrenocortical system
[6–8].
Echinacea is another well-known herb with a worldwide
reputation. There is widespread interest in the therapeutic
and preventive potential of echinacea [7]. Echinacea angus-
tifolia, E. pallida,a n dE. purpurea are the species most often
used medicinally [9, 10]. It has been reported that echinacea
has carbohydrate, glycoside, alkaloide, alkylamide, and poly-
acetylene structures as active ingredients. Echinacea is com-
monly used for the prevention and treatment of upper res-
piratory tract infections (URTIs), viral, bacterial, and fungal
infections, complementary therapy for cancer chemotherapy
to support the immune system, chronic fatigue syndrome,
acquired immunodeﬁciency diseases (AIDs), and snake bites
[11].
In the current study, we determined the expression of IL-
10 and TGF-β1 mRNA as antiinﬂammatory cytokines and
TNF-α as a proinﬂammatory cytokine in healthy rats fed
ginseng and echinacea.2 The Scientiﬁc World Journal
Table 1:StatisticalanalysissummaryofresultsobtainedfromechinaceaversuscontrolafterprocessingRT-PCRdatathroughREST(Relative
Expression Software Tool) in 20th day.
Gene Type Reaction eﬃciency Expression Std. error 95% CI P (H1) Result
GAPDH REF 0,91 1,000 0,501–2,050 0,313–2,909 1,000
IL-10 TRG 0,91 4,053 0,956–12,147 0,867–22,956 0,131
TGF-β1 TRG 1,0 2,569 0,715–8,246 0,334–19,656 0,472
TNF-α TRG 0,91 5,042 2,078–13,565 0,944–23,456 0,035 UP
Normalisation factor of the parameters used for analysis was 0.40.
Table 2: Statistical analysis summary of results obtained from ginseng versus control after processing RT-PCR data through REST (Relative
Expression Software Tool) in 20th day.
Gene Type Reaction eﬃciency Expression Std. error 95% CI P (H1) Result
GAPDH REF 0,91 1,000 0,497–1,970 0,295–3,419 1,000
IL-10 TRG 0,91 12,304 4,545–33,116 2,140–61,238 0,041 UP
TGF-β1 TRG 1,0 1,179 0,556–2,755 0,464–4,988 1,000
TNF-α TRG 0,91 8,468 4,847–19,217 2,357–24,843 0,065
Normalisation factor of the parameters used for analysis was 0.18.
2.MaterialsandMethods
Ginseng and echinacea roots were commercial products
(General Nutrition Products (GNC), Inc., 1050 Woodruﬀ
Road Greenville, SC, USA). In this study, 48 healthy Fischer
344 male rats were used. The rats were divided into three
equal groups. The mean weights of the groups were similar.
The animals were kept in individual cages for 40 days and
fed ad libitum. The control group (C) was fed standard rat
pellets, the ginseng group (G), and echinacea group (E) were
fed pellets containing 0.5g/kg of P. ginseng root powder
and 0.75g/kg of E. purpurea root powder, respectively. On
the 20th and 40th days of the study, citrated blood samples
were obtained from 8 animals in each group. The Ethical
CommitteeoftheFacultyofVeterinaryMedicine(Reportno.
2007/036) approved the study protocol.
2.1. Total RNA Isolation and cDNA Synthesis. Leucocyte
isolation was performed using red blood cell lysis buﬀer
(RBCLB; Roche Diagnostics, Mannheim, Germany). Total
RNA was isolated using components and instructions from
the High Pure RNA Isolation Kit (Roche Diagnostics,
Mannheim, Germany) in the leucocyte pellet. The total
elution volume of RNA was 50mL in the ﬁnal step. RNA was
stored at −80◦C until used in a cDNA preparation reaction.
Total RNA was used as a template for reverse transcription
(RT) in 20mL volumes, as described in the 1st Strand cDNA
Synthesis Kit for RT-PCR (Roche Diagnostics, Mannheim,
Germany). In the RT reaction, we used random hexamer
primers. The cDNA was stored at −20◦C until used in
real-time PCR in a LightCycler (LC; Roche Diagnostic Ltd.,
Lewes, UK).
2.2. Real-Time PCR. Real-time PCR was performed for
the quantiﬁcation of gene expression using a LC rapid
thermal system (Roche) according to the manufacturer’s
instructions. A LightCycler FastStart DNA Master SYBR
Green I kit (Roche Diagnostics, Mannheim, Germany) was
used together with LightCycler-Primer Set Kits (Search-
LC, Heidelberg, Germany) for IL-10, TNF-α,a n dT G F -
β1, and a housekeeping gene (glyceraldehyde phosphate
dehydrogenase (GAPDH)). Reactions were performed in a
20μLv o l u m ew i t h1 0μLo fm a s t e rm i x( 2μLo fS y b r G r e e n
mix, 2μL of speciﬁc primers for each cytokine, and 6μL
of sterile water) and 10μLo fc D N At e m p l a t e .T h er u n
was programmed according to the LightCycler-Primer Set
Kits instructions. The ﬁrst step was a 10min denaturation
at 95◦C, followed by 35 cycles for GAPDH, 45 cycles for
the remaining cytokines, a 95◦C denaturation for 10sec,
68◦C–58◦C annealing for 10sec (decreasing 0.5◦C/cycle),
and ﬁnally a 72◦C extension for 16sec. The PCR products
were subjected to melting curve-analyses starting with 58◦C,
and increasing to 95◦C( 0 . 1 ◦C/sec) to conﬁrm product
speciﬁcity. The results were expressed as a ratio between
the concentration of the housekeeping gene (GAPDH) and
the relevant cytokine in each sample. RNA input was
normalized by the average expression of the housekeeping
genes encoding GAPDH.
The statistical diﬀerences among the groups were tested
by REST software 2005 [12].
3. Results
In the current study, it was determined that the expression
of IL-10 mRNA was not diﬀerent between the C and E
groups (Table 1 and Figure 1); however, the expression of
IL-10 mRNA increased signiﬁcantly in the G group when
compared to the C group (Table 2 and Figure 2, P<0.05) as
a result of feeding 20 days with feeds including ginseng and
echinacea. The expression of IL-10mRNA on day 40 oftreat-
ment was not diﬀerent between the groups (Tables 3 and 4
and Figures 3 and 4). It was also shown that the expression of
I L - 1 0m R N Ai ne a c hg r o u po nd a y s2 0a n d4 0o ft r e a t m e n t
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Table 3:StatisticalanalysissummaryofresultsobtainedfromechinaceaversuscontrolafterprocessingRT-PCRdatathroughREST(Relative
Expression Software Tool) in 40th day.
Gene Type Reaction eﬃciency Expression Std. Error 95% CI P (H1) Result
GAPDH REF 0,91 1,000 0,270–3,369 0,086–11,659 1,000
IL-10 TRG 0,91 1,707 0,369–5,595 0,233–11,811 0,263
TGF-β1 TRG 0,91 0,837 0,404–1,686 0,248–3,303 0,508
TNF-α TRG 0,91 1,587 0,583–4,967 0,307–8,978 0,241
Normalisation factor of the parameters used for analysis was 1.00.
Table 4: Statistical analysis summary of results obtained from ginseng versus control after processing RT-PCR data through REST (Relative
Expression Software Tool) in 40th day.
Gene Type Reaction eﬃciency Expression Std. Error 95% CI P (H1) Result
GAPDH REF 0,91 1,000 0,443–2,742 0,230–7,522 1,000
IL-10 TRG 0,91 1,533 0,394–4,632 0,200–6,599 0,502
TGF-β1 TRG 0,91 1,522 0,446–8,461 0,263–25,741 0,565
TNF-α TRG 0,91 0,897 0,463–1,689 0,246–2,596 0,876
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Figure 1: Relative expressions of IL-10, TGF-β1, and TNF-α
obtained from echinacea versus control after processing RT-PCR
with REST in 20th day.
There was no diﬀerence between the groups with respect
to the expression of TGF-β1 mRNA on the 20th and 40th
days of treatment (Tables 1, 2, 3,a n d4 and Figures 1, 2,
3,a n d4). It was also shown that the expression of TGF-β1
mRNA in each group on days 20 and 40 of treatment was not
statistically diﬀerent.
The expression of TNF-α mRNA in the E group on the
20th day of treatment was signiﬁcantly higher than the C
group (Table 1 and Figure 1, P<0.05). In addition, there
was no signiﬁcant diﬀerence between groups with respect to
the expression of TNF-α mRNA on the 40th day of treatment
(Tables 3 and 4 and Figures 3 and 4). In contrast, the
expression of TNF-α mRNA obtained on days 20 and 40 of
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Figure 2: Relative expressions of IL-10, TGF-β1, and TNF-α
obtained from ginseng versus control after processing RT-PCR with
REST in 20th day.
4. Discussion
The administration of ginseng for 20 days increased the
expression of IL-10 mRNA signiﬁcantly (P<0.05) when
compared to the C group (Table 2 and Figure 2), and this
increasewasinagreementwiththeﬁndingsobtainedbyLiou
et al. [13] and Wang et al. [14] using mouse cell cultures in
which a ginseng extract was used.
In contrast, Larsen et al. [15] reported that ginseng
extract did not change IL-10 production in polymorphonu-
clear leukocytes, while Lee et al. [16] showed that the
addition of ginseng extract in human monocytic cell cultures
decreased the expression of IL-10. The equilibrium that
should exist between pro- and anti-inﬂammatory cytokines
in various infections and inﬂammatory states is critical
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Figure 3: Relative expressions of IL-10, TGF-β1, and TNF-α ob-
tained from echinacea versus control after processing RT-PCR with
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Figure 4: Relative expressions of IL-10, TGF-β1, and TNF-α ob-
tained from ginseng versus control after processing RT-PCR with
REST in 40th day.
excessive immune response may result in more harm than
an infection or various noxious agents cause in humans [17].
TheincreaseintheexpressionofIL-10andsuppressionofIL-
2 production in T cells following ginseng application and the
corresponding limited proliferation in B and T cell lines and
decrease in immunoglobulin production in B cells support
this opinion [13].
In addition, it is diﬃcult to explain the lack of diﬀerence
inIL-10mRNAexpressionintheGgroupcomparedtotheC
group on day 40 of treatment (Table 4 and Figure 4), because
the eﬀect of ginseng treatment on the expression of IL-10
mRNA as a function of time, if any, is unknown.
The expression of IL-10 mRNA of the E group on
the 20th day of the study was not diﬀerent from the C
group (Table 1 and Figure 1). While Gertsch et al. [18]
deﬁned that the addition of echinacea extract in human
peripheral mononuclear cell cultures increased IL-10 expres-
sion, Hwang et al. [19] reported that the addition of
echinacea to mouse splenocyte cell cultures increased IL-
10 expression, and Raduner et al. [20] concluded that the
addition of echinacea alkylamide to human peripheral whole
blood cell cultures increased the expression of IL-10. In
contrast, Guiotto et al. [21] showed that oral echinacea
in various doses in humans decreased the expression of
IL-10 and Zhai et al. [22] reported that there was no
diﬀerence in the expression of IL-10 by LPS stimulation in
mononuclear leucocyte cell cultures obtained from mice that
h a dr e c e i v e da no r a le c h i n a c e ae x t r a c tw h e nc o m p a r e dt o
the control group. Echinacea or alkylamides ﬁrst stimulate
a proinﬂammatory response, then an antiinﬂammatory
response; this time-dependent bimodal eﬀect is important in
immunomodulation [23].
While variations in TGF-β mRNA following echinacea
treatment were not observed in the current study, Randolph
et al. [23] reported that the expression of TGF-β mRNA
decreased in cell cultures which were treated with diﬀerent
echinacea extracts (E. purpurea and E. angustifolia). While
a signiﬁcant increase or decrease was not observed in the
TGF-β level following ginseng treatment in the current
study, diﬀerent statements suggested that the TGF-β1l e v e l
increased or decreased in the research conducted with single
or combined application of various saponins that are active
and contained in this plant or in the root of the plant.
Kanzaki et al. [24] stated that ginseng saponin appli-
cation in human ﬁbroblast cultures increased the TGF-β1
level. An increase in TGF-β1 depends on saponin; therefore,
the materials eﬀective in extracellular matrix formation,
such as ﬁbronectin, may be beneﬁcial in tissue repair and
wound healing [24]. In contrast, Han et al. [25]c o n c l u d e d
that ginseng administered to mice intraperitoneally 24
hours before irradiation decreased the expression of TGF-β1
mRNA and aﬀected antioxidant activity positively; Han et al.
[25] supported their opinion based on the ﬁndings of Chang
et al. [26] and Martin et al. [27]i nw h i c hT G F - β increased
radicals, such as ROS and HO, causing oxidative damage.
While ginsengdidnotcauseasigniﬁcantalterationinthe
expression of TNF-α mRNA in this study, Wang et al. [28]
stated that a ginseng extract did not result in any alterations
in the expression of TNF-α mRNA in mouse macrophages.
In contrast, Rivera et al. [29] reported that ginsenoside Rb1
increased TNF-α titration in lymphocyte cultures obtained
from mice after parvovirus inoculation, while Song et al.
[30] concluded that there was an increase in the expression
of TNF-α mRNA by ginseng extract application in murine
peritoneal macrophage cell cultures. In contrast, Huang
et al. [31] stated that the addition of ginseng extract in
human lymphocyte cell cultures decreased the expression
of TNF-α,a n dK i me ta l .[ 32] showed that the addition
of ginsenoside Rb1 to human peripheral mononuclear cell
cultures decreased the expression of TNF-α and there was
also a decrease in the expression of TNF-α when given orally
to mice with arthritis. In these studies with ginseng, diﬀerent
results and decisions should be evaluated with various
ginseng content, diﬀerent systems, and varying amounts.
Randolph et al. [23] and Gertsch et al. [18] stated that
the addition of echinacea extract to human monocytic cell
culturesandechinaceaalkylamidetohumanmacrophagecell
cultures increased the expression of TNF-α mRNA, which
supported the increase in the expression of TNF-α mRNA
in the E group in the current study. In parallel with theseThe Scientiﬁc World Journal 5
ﬁndings, it was determined that echinacea root powder or
extracts increased the TNF-α l e v e li nc e l lc u l t u r e st r e a t e d
with LPS [22] and in infected cell cultures [33]. In contrast,
oral echinacea in humans in various doses [21] and the
addition of echinacea extract to human peripheral whole
blood cultures [20] decreased the TNF-α level.
In the studies which showed that echinacea extracts or
preparations decreased or increased cytokines, such as TNF-
α, it was suggested that this material modulated the immune
system both as a stimulator and as an inhibitor via CB2
receptors [18]. It was determined that the diﬀerent results
obtained with the echinacea studies were correlated with the
content from diﬀerent kinds and parts of this plant [20].
When the increase in the expression of IL-10 mRNA by
ginseng was taken into consideration in this study, it can be
concluded that this plant is eﬀective in immunomodulation.
In the E group of this study, the increase in the expression
of TNF-α mRNA was considered with some cytokines (IL-1,
IL-6, NO, and IFN-γ) not measured in our study, supporting
the opinion that echinacea modulates and stimulates the
immune system. Because no variations occurred in the
expression of TGF-β1 mRNA by ginseng or echinacea in the
amounts used in the current study, it cannot be concluded
that these plants have no eﬀect on TGF-β1.
Given the complexity of the immune system, the interac-
tion with other systems and the multifunctionality of mea-
sured cytokines were taken into consideration, more detailed
and diﬀerent studies should be conducted to conﬁrm the
results.
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